Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: A before-after study

Transfusion

Volumn 56, Issue 3, 2016, Pages 673-681

  Rineau, Emmanuel ^a   Chaudet, Aurélie ^a   Chassier, Claire ^a   Bizot, Pascal ^b   Lasocki, Sigismond ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC CARBOXYMALTOSE; FERROUS SULFATE; HEMOGLOBIN; IRON SACCHARATE; RECOMBINANT ERYTHROPOIETIN; TARDYFERON; TRANEXAMIC ACID; FERRIC ION; MALTOSE;

ABDOMINAL PAIN; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CONSTIPATION; DIARRHEA; DRUG WITHDRAWAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MAJOR SURGERY; NAUSEA; OBSERVATIONAL STUDY; ORTHOPEDIC SURGEON; PERIOPERATIVE PERIOD; POSTOPERATIVE ANEMIA; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; SIDE EFFECT; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; URINARY TRACT INFECTION; ADULT; ANALOGS AND DERIVATIVES; EPIDEMIOLOGY; FEMALE; HIP REPLACEMENT; KNEE REPLACEMENT; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE PERIOD; PROCEDURES;

ADULT; ANEMIA; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; CONTROLLED BEFORE-AFTER STUDIES; ERYTHROPOIETIN; FEMALE; FERRIC COMPOUNDS; HUMANS; MALE; MALTOSE; ORTHOPEDIC PROCEDURES; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84960120293     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13468     Document Type: Article

References (54)

1. Spahn DR., Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113: 482-95.
2. Lasocki S, Krauspe R, von Heymann C, et al., PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol 2015; 32: 160-7.
3. Wu WC, Schifftner TL, Henderson WG, et al., Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-8.
4. Beattie WS, Karkouti K, Wijeysundera DN, et al., Risk associated with preoperative anemia in noncardiac surgery. Anesthesiology 2009; 110: 574-81.
5. Musallam KM, Tamim HM, Richards T, et al., Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-407.
6. Carson JL, Duff A, Poses RM, et al., Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60.
7. Rosencher N, Kerkkamp HE, Macheras G, et al., Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
8. Carson JL, Altman DG, Duff A, et al., Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39: 694-700.
9. Innerhofer P, Klingler A, Klimmer C, et al., Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 2005; 45: 103-10.
10. Weber EW, Slappendel R, Prins MH, et al., Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg 2005; 100: 1416-21.
11. Glance LG, Dick AW, Mukamel DB, et al., Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011; 114: 283-92.
12. Goodnough LT, Maniatis A, Earnshaw P, et al., Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
13. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al., Management of severe perioperative bleeding. Eur J Anaesthesiol 2013; 30: 270-382.
14. Shander A, Van Aken H, Colomina MJ, et al., Patient blood management in Europe. Br J Anaesth 2012; 109: 55-68.
15. Spahn DR, Goodnough LT., Alternatives to blood transfusion. Lancet 2013; 381: 1855-65.
16. Kotzé A, Carter LA, Scally AJ., Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108: 943-52.
17. Doodeman HJ, van Haelst IM, Egberts TC, et al., The effect of a preoperative erythropoietin protocol as part of a multifaceted blood management program in daily clinical practice (CME). Transfusion 2013; 53: 1930-9.
18. Enko D, Wallner F, von-Goedecke A, et al., The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients. Anemia 2013; 2013: 641876.
19. Zufferey P, Merquiol F, Laporte S, et al., Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006; 105: 1034-46.
20. Ker K, Edwards P, Perel P, et al., Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
21. Muñoz M, Naveira E, Seara J, et al., Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. Br J Anaesth 2012; 108: 532-4.
22. Muñoz M, Gómez-Ramírez S, Cuenca J, et al., Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014; 54: 289-99.
23. Beris P, Muñoz M, García-Erce JA, et al., Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
24. Rosencher N, Bellamy L, Chabbouh T, et al., Blood conservation approaches in orthopedic surgery. Transfus Clin Biol 2008; 15: 294-302.
25. Carson JL, Terrin ML, Noveck H, et al., Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62.
26. Assessing the iron status of populations [Internet]. Geneva: WHO. 2007 [cited 2015 Dec 31]. Available from: http://www.who.int/nutrition/publications/micronutrients/anaemia-iron-deficiency/9789241596107.pdf.
27. Rineau E, Chaudet A, Carlier L, et al., Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery. Br J Anaesth 2014; 113: 296-8.
28. Shander A, Hofmann A, Ozawa S, et al., Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-65.
29. Faris P., Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med 1996; 101: 28S-32S.
30. Laupacis A, Feagan B, Wong C., Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. COPES Study Group. Lancet 1993; 342: 378.
31. Alsaleh K, Alotaibi GS, Almodaimegh HS, et al., The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials. J Arthroplasty 2013; 28: 1463-72.
32. Olijhoek G, Megens JG, Musto P, et al., Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion 2001; 41: 957-63.
33. Gafter-Gvili A, Rozen-Zvi B, Vidal L, et al., Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia-systematic review and meta-analysis of randomised controlled trials. Acta Oncol 2013; 52: 18-29.
34. Rozen-Zvi B, Gafter-Gvili A, Paul M, et al., Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis. Am J Kidney Dis 2008; 52: 897-906.
35. Auerbach M, Ballard H, Glaspy J., Clinical update: intravenous iron for anaemia. Lancet 2007; 369: 1502-4.
36. Notebaert E, Chauny JM, Albert M, et al., Short-term benefits and risks of intravenous iron: a systematic review and meta-analysis. Transfusion 2007; 47: 1905-18.
37. Litton E, Xiao J, Ho KM., Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ 2013; 347: f4822.
38. Lyseng-Williamson KA, Keating GM., Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009; 69: 739-56.
39. Bonnar J, Goldberg A, Smith JA., Do pregnant women take their iron? Lancet 1969; 1: 457-8.
40. Kerr DN, Davidson S., Gastrointestinal intolerance to oral iron preparations. Lancet 1958; 2: 489-92.
41. Nordeng H, Eskild A, Nesheim BI, et al., Guidelines for iron supplementation in pregnancy: compliance among 431 parous Scandinavian women. Eur J Clin Pharmacol 2003; 59: 163-8.
42. Hyder SM, Persson LA, Chowdhury AM, et al., Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy. J Health Popul Nutr 2002; 20: 175-9.
43. Bisbe E, Moltó L, Arroyo R, et al., Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth 2014; 113: 402-9.
44. Krayenbuehl PA, Battegay E, Breymann C, et al., Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood 2011; 118: 3222-7.
45. Lasocki S, Chudeau N, Papet T, et al., Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study. Crit Care 2014; 18: 542.
46. Piednoir P, Allou N, Driss F, et al., Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study. Eur J Anaesthesiol 2011; 28: 796-801.
47. Brutsaert TD, Hernandez-Cordero S, Rivera J, et al., Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 2003; 77: 441-8.
48. Brownlie T, Utermohlen V, Hinton PS, et al., Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004; 79: 437-43.
49. Hinton PS, Giordano C, Brownlie T, et al., Iron supplementation improves endurance after training in iron-depleted, nonanemic women. J Appl Physiol 2000; 88: 1103-11.
50. Anker SD, Comin Colet J, Filippatos G, et al., Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361: 2436-48.
51. Comin-Colet J, Lainscak M, Dickstein K, et al., The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J 2012; 34: 30-8.
52. Agarwal R., Nonhematological benefits of iron. Am J Nephrol 2007; 27: 565-71.
53. Conlon NP, Bale EP, Herbison GP, et al., Postoperative anemia and quality of life after primary hip arthroplasty in patients over 65 years old. Anesth Analg 2008; 106: 1056-61.
54. Ye X, Lafuma A, Torreton E, et al., Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses. BMC Health Serv Res 2013; 13: 186.